NASDAQ:TKNO Alpha Teknova (TKNO) Stock Forecast, Price & News $2.70 -0.09 (-3.23%) (As of 09:02 AM ET) Add Compare Share Share Today's Range$2.70▼$2.7050-Day Range$1.66▼$3.4452-Week Range$1.62▼$6.48Volume566 shsAverage Volume72,243 shsMarket Capitalization$76.52 millionP/E RatioN/ADividend YieldN/APrice Target$9.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Alpha Teknova MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside234.5% Upside$9.33 Price TargetShort InterestHealthy0.29% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.64Based on 8 Articles This WeekInsider TradingAcquiring Shares$14.45 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.05) to ($0.79) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.24 out of 5 starsMedical Sector387th out of 968 stocksDiagnostic Substances Industry6th out of 13 stocks 3.0 Analyst's Opinion Consensus RatingAlpha Teknova has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.33, Alpha Teknova has a forecasted upside of 234.5% from its current price of $2.79.Amount of Analyst CoverageAlpha Teknova has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.29% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Alpha Teknova has recently increased by 83.81%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlpha Teknova does not currently pay a dividend.Dividend GrowthAlpha Teknova does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TKNO. Previous Next 3.1 News and Social Media Coverage News SentimentAlpha Teknova has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Alpha Teknova this week, compared to 1 article on an average week.Search Interest2 people have searched for TKNO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Alpha Teknova to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alpha Teknova insiders have bought more of their company's stock than they have sold. Specifically, they have bought $14,447,997.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders17.20% of the stock of Alpha Teknova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.82% of the stock of Alpha Teknova is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Alpha Teknova are expected to grow in the coming year, from ($1.05) to ($0.79) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Teknova is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Teknova is -1.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Teknova has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Alpha Teknova (NASDAQ:TKNO) StockAlpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.Read More TKNO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TKNO Stock News HeadlinesSeptember 30, 2023 | americanbankingnews.comFY2023 EPS Estimates for Alpha Teknova, Inc. (NASDAQ:TKNO) Raised by KeyCorpSeptember 27, 2023 | finance.yahoo.comTeknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process DevelopmentOctober 2, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.September 27, 2023 | finance.yahoo.comTeknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process DevelopmentSeptember 24, 2023 | americanbankingnews.comAlpha Teknova, Inc. (NASDAQ:TKNO) Director Buys $1,499,998.50 in StockSeptember 23, 2023 | americanbankingnews.comTelegraph Hill Partners Iv, L. Purchases 6,917,837 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) StockSeptember 19, 2023 | finance.yahoo.comTeknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit FacilitySeptember 18, 2023 | finance.yahoo.comTeknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private PlacementOctober 2, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.August 16, 2023 | finance.yahoo.comTeknova Announces New Board Member, Martha J. DemskiAugust 14, 2023 | finance.yahoo.comAlpha Teknova, Inc. (NASDAQ:TKNO) Q2 2023 Earnings Call TranscriptAugust 14, 2023 | finance.yahoo.comNewsflash: Alpha Teknova, Inc. (NASDAQ:TKNO) Analysts Have Been Trimming Their Revenue ForecastsAugust 11, 2023 | finance.yahoo.comTeknova Reports Second Quarter 2023 Financial ResultsAugust 9, 2023 | finance.yahoo.comTeknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences ReagentsJuly 27, 2023 | finance.yahoo.comTeknova to Report Second Quarter 2023 Financial Results on August 10, 2023July 20, 2023 | finance.yahoo.comTeknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX PlatformJuly 16, 2023 | finance.yahoo.comDespite Recent Gains, Alpha Teknova Insiders Are Still Down US$51kJuly 12, 2023 | markets.businessinsider.comAlpha Teknova Set to Prosper from Expected Boom in Cell & Gene Therapies: KeyBanc AnalystJuly 12, 2023 | markets.businessinsider.comAlpha Teknova (TKNO) Receives a Hold from KeyBancJuly 11, 2023 | finance.yahoo.comTeknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process DevelopmentJuly 11, 2023 | finance.yahoo.comTeknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process DevelopmentJuly 6, 2023 | msn.comAlpha Teknova (TKNO) Price Target Decreased by 6.67% to 7.14June 5, 2023 | finance.yahoo.comAmidst increasing losses, Investors bid up Alpha Teknova (NASDAQ:TKNO) 18% this past weekMay 11, 2023 | msn.comRecap: Alpha Teknova Q1 EarningsMay 10, 2023 | finance.yahoo.comTeknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual MeetingMay 4, 2023 | finance.yahoo.comWhat Makes Alpha Teknova (TKNO) a New Strong Buy StockMay 4, 2023 | finance.yahoo.comTeknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023See More Headlines Receive TKNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter. Email Address TKNO Company Calendar Last Earnings8/10/2023Today10/02/2023Next Earnings (Estimated)11/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TKNO CUSIPN/A CIK1850902 Webwww.teknova.com Phone831-637-1100FaxN/AEmployees285Year FoundedN/APrice Target and Rating Average Stock Price Forecast$9.33 High Stock Price Forecast$12.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+245.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.83) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,470,000.00 Net Margins-131.88% Pretax Margin-134.87% Return on Equity-36.01% Return on Assets-23.97% Debt Debt-to-Equity RatioN/A Current Ratio1.50 Quick Ratio1.09 Sales & Book Value Annual Sales$41.42 million Price / Sales1.85 Cash FlowN/A Price / Cash FlowN/A Book Value$3.56 per share Price / Book0.76Miscellaneous Outstanding Shares28,340,000Free Float23,466,000Market Cap$76.52 million OptionableNot Optionable Beta-0.24 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Stephen Gunstream (Age 43)Pres, CEO & Director Comp: $697.14kMr. Matthew C. Lowell (Age 52)Chief Financial Officer Comp: $477.86kMr. Ken Gelhaus (Age 40)Chief Commercial Officer Comp: $482.52kMr. Damon A. Terrill (Age 52)Gen. Counsel, Chief Compliance Officer & Sec. Ms. Jennifer HenrySr. VP of MarketingMs. Lisa Hood McCann (Age 41)Chief People Officer More ExecutivesKey CompetitorsAchieve Life SciencesNASDAQ:ACHVVolitionRxNYSE:VNRXAspira Women's HealthNASDAQ:AWHImmuCellNASDAQ:ICCCTrinity BiotechNASDAQ:TRIBView All CompetitorsInsiders & InstitutionsTelegraph Hill Partners Iv, L.Bought 6,917,837 shares on 9/19/2023Total: $12.80 M ($1.85/share)J Matthew MackowskiBought 810,810 shares on 9/19/2023Total: $1.50 M ($1.85/share)Matthew LowellBought 54,054 shares on 9/19/2023Total: $99,999.90 ($1.85/share)Damon TerrillBought 27,027 shares on 9/19/2023Total: $49,999.95 ($1.85/share)Y Intercept Hong Kong LtdBought 44,757 shares on 8/15/2023Ownership: 0.159%View All Insider TransactionsView All Institutional Transactions TKNO Stock - Frequently Asked Questions Should I buy or sell Alpha Teknova stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alpha Teknova in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TKNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TKNO, but not buy additional shares or sell existing shares. View TKNO analyst ratings or view top-rated stocks. What is Alpha Teknova's stock price forecast for 2023? 1 equities research analysts have issued 12 month price objectives for Alpha Teknova's shares. Their TKNO share price forecasts range from $8.00 to $12.00. On average, they predict the company's share price to reach $9.33 in the next year. This suggests a possible upside of 245.7% from the stock's current price. View analysts price targets for TKNO or view top-rated stocks among Wall Street analysts. How have TKNO shares performed in 2023? Alpha Teknova's stock was trading at $5.64 on January 1st, 2023. Since then, TKNO stock has decreased by 52.1% and is now trading at $2.70. View the best growth stocks for 2023 here. Are investors shorting Alpha Teknova? Alpha Teknova saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 82,900 shares, an increase of 83.8% from the August 31st total of 45,100 shares. Based on an average daily volume of 35,300 shares, the days-to-cover ratio is currently 2.3 days. Approximately 0.3% of the company's shares are short sold. View Alpha Teknova's Short Interest. When is Alpha Teknova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023. View our TKNO earnings forecast. How were Alpha Teknova's earnings last quarter? Alpha Teknova, Inc. (NASDAQ:TKNO) released its earnings results on Thursday, August, 10th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.01. The company earned $11.53 million during the quarter, compared to analysts' expectations of $9.60 million. Alpha Teknova had a negative net margin of 131.88% and a negative trailing twelve-month return on equity of 36.01%. What guidance has Alpha Teknova issued on next quarter's earnings? Alpha Teknova updated its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $37.00 million-$40.00 million, compared to the consensus revenue estimate of $43.12 million. When did Alpha Teknova IPO? (TKNO) raised $90 million in an initial public offering on Friday, June 25th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share. What is Alpha Teknova's stock symbol? Alpha Teknova trades on the NASDAQ under the ticker symbol "TKNO." How do I buy shares of Alpha Teknova? Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Alpha Teknova's stock price today? One share of TKNO stock can currently be purchased for approximately $2.70. How much money does Alpha Teknova make? Alpha Teknova (NASDAQ:TKNO) has a market capitalization of $76.52 million and generates $41.42 million in revenue each year. The company earns $-47,470,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis. How many employees does Alpha Teknova have? The company employs 285 workers across the globe. How can I contact Alpha Teknova? The official website for the company is www.teknova.com. The company can be reached via phone at 831-637-1100 or via email at investors@teknova.com. This page (NASDAQ:TKNO) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.